StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
The company has a market capitalization of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90. Athersys has a 52-week low of $0.01 and a 52-week high of $1.99.
Athersys Company Profile
Featured Articles
- Five stocks we like better than Athersys
- Find and Profitably Trade Stocks at 52-Week Lows
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- How to Invest in Blue Chip Stocks
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- What is a Secondary Public Offering? What Investors Need to Know
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.